Visceral adipose tissue-derived serine protease inhibitor (vaspin) decreases NLRP3 levels in an autophagy-dependent mechanism in STZ-induced diabetes model, associated with the improvement of a systolic function (31). Here, NLRP3 is linked to diabetes mellitus.